Entheon Biomedical Corp.
ENTBF
$0.081
-$0.0035-4.14%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | 0.00 | 96.00K | 184.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00 | 0.00 | 96.00K | 184.90K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 0.00 | 0.00 | 96.00K | 184.90K |
| SG&A Expenses | 244.10K | 236.80K | 260.10K | 303.80K | 415.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 244.10K | 236.80K | 260.10K | 303.80K | 415.80K |
| Operating Income | -244.10K | -236.80K | -260.10K | -207.70K | -230.80K |
| Income Before Tax | -233.20K | -226.20K | -250.20K | -207.30K | -222.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.23 | -0.23 | -0.25 | -0.21 | -0.22 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -233.20K | -226.20K | -250.20K | -207.30K | -222.50K |
| EBIT | -244.10K | -236.80K | -260.10K | -207.70K | -230.80K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.03 | -0.03 | -0.04 | -0.04 | -0.04 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.03 | -0.02 | -0.03 |
| EPS Diluted | -0.03 | -0.03 | -0.04 | -0.04 | -0.04 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.03 | -0.02 | -0.03 |
| Average Basic Shares Outstanding | 30.94M | 28.00M | 25.05M | 23.64M | 23.64M |
| Average Diluted Shares Outstanding | 30.94M | 28.00M | 25.05M | 23.64M | 23.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |